Medical records of a 33 year-old Iraqi detainee who was shot in the right thigh causing a fractured femur and he also suffered third (3rd) degree burns to both feet. The medical records do not state how the detainee received his injuries and does not give any personal information on the detainee.
RAPIDPOINT COAG ANALYInc-/V4.54
SERIAL 1111111, 09/29/03 05:0° PM
..
.
Patient ID: MIN ((;-)
lest Name :PT
lest Result: , 16.8 sec.
***RESULT NOT RANGE CHECKED***
Ratio =
CliPiegirtti: 1101"P"mlife
Acitrated wh. blood'
Test Date ,A9/29/03
Test Time :05:01 PM
Card Lot.
Sample T7:
:0403
Operator
RAPIDPOINT COAG ANALYZER V4,54
09/29/03 05:05 PM
SERIAL
Patient ID: 111111
Test Name :APTT
Test Result: , 37.5 sec.
***RESULT NOT RANGE CHECKED***
Sample Type:citrated wh. blood
Test Date :09/29/03
Test Time :05:03 PM
Card Lot.
:100208
Operator
' ANALYZER V4.54
SERIAL.
09/29/03 05:21 AM
Patien
/Te§t Name :PT
Test Result:= 15.0 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1.2
Calculated INR = 1.40
Sample Type:citrated wh, blood
Test Date :09/29/03
Test Time :05:19 AM
Card Lot.
:040302
Operator
RAPIDPOINT COAG ANALYZER V4.54
SERIAL 41111111,09/29/03 05:24 AM
I -
Test Name :APTT
Test Result:= 36.4 sec.
***RESULT NOT RANGE CHECKED***
Sample .Type:citrated wh. blood
Test Date :09/29/03
Test Time :05:21 AM
Card Lot.
:10
Operator
!!.f COAG-mrAfVER V4.54
09/29/03 01:15 PM
-,„
Patient ID:
Test Name :PJ
Test RestilI:= 18,1 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1.5
Calculated INR = 1.89
Sample Type:citrated wh. blood
Test Date :09/29/03
Test Time :01:14 PM
Card Lot.
:04030
Operator
L
RAPIDPOINT COAG ANALYZER V4.54
SERIAL 109/29/03 01:18 PM
Patient ID:1M 2 Test Name :APTT Test Result:= 42.8 sec. ***RESULT NOT RANGE CHECKED*** Sample Type:citrated wh. blood Test Date :09/29/03
st Time :01:16 PM
d Lot.
:100208
-.-ffator
VP .7q11
Patient
4.'5.
FT: 191 z1!) -6/11
Hgb 10.7 L 12.0
VII 15.0 H 10.5
II!,.
Hct 34.0 L . 0
:5.0.
.97.r.i ft. B0.:
ra 27.5 pg :1.0
Eq: 31.5 1. g/d1. 310 27.0
Flt 511. Y10':."t!
H 50.
LIZ 5-2 2::.5 51.1
t,
LY# r.s.C' IA_ 14
1 1.:
VK 16.1 H :110':/tL
F22: 4,0c'
Ngi-, 11.1
FLt 36.0
E17.8 fL
ra 27.2 p3
!INC .31.0 L s/d
FIt
5CZ..
H
Lib 13.'rr.
41 Z
Lft *
Liits
4.5 10.F
MO 6.00
WO 12.0
60.0
27:0 31.
2;2.5 51.1
1,2 3,4
MEDCOM - 19641
DOD-033215
. . . • . •.
\
›. -1 0.
ON 01
o 2 E
0
0
2
2 2
EE
a
a E
o
EE
a
0.
co a W
0)
zb mmo l/L
_127mmo l/L
27 mmol/L
4.2 mmol/L
*calculated
E W 0
a, 0*
P.'tien Tetmp:
Lo 0)
0
I
0
rs-
LI
r
N 0) LI *
Rt Patient
0
0
0.
a
-U)
• 4r
N
0 * 0 04 0 04
0
N
2 0 0
O. O. 0.
0 0 L
rr CL Nal
.
0 LI .0 o o (...N
0.
• Z LL
I-
Itl
CL
a
I-5TRT EG 7+ 717
127 mmol/L
4.5 mmol/L
¦J
28 mmo l/L
--5 Pt Name:
—I
0. ON
0.
•.
O 0 0
=
E E M
a
a a
.E E
O0 Na 125 mmol/L
K. 4.2 mmol/L
O.
TCAZ 28 mmol/L
0)
I- 0
O.
dI 1.01 mmol/L
Lu iCa
ry
U) 0)
N W N
•ml
*calculated
N *
CM
LI •
r.
U
=
TO
N
0
•-• V)
0. 0
32 :PCV
Hct
0 0,1 0
LI .0
E CM dI
0.
C.J d L1
LL CL
0
Hb* 11 g/dL
r
a 0. CI Q. 2
0
\
0
0
a
.4)1
•¦•
N.
*via Hct
At S7C
PH
7.453
PCO2
38.1 mmHg
PO2 104 mmHg
mmol/L
HCO3
BEecf 4 mmol/L
502* ,8
*calculated
0)
r'.
ara
I-
0
N
0)
0
I
*calculated
0 01
. ti 0
I-
0. CL
LL
Sample Type_
305EP03
00:11
t\J
Oper:
Physician:
Ser# 11111
Ver:
-/
11111110
-4 -I
r¦-•
O0 EE
0
CV
1. 15 mmo l/L
1E7 mmo l/L
'S. IL.
-4
-J ON N
"0 x = 0 0 T. 2
a a a a E. la
Cr. E a a E . E 0 0 J-1
CL ••-1
N . 0,
PatientTemp:
Sample Type_ :
* C,)' I
LI I I
MI 0
0) U
N
0
CO *
CJ
LL
0 1_1 .0 O 0
I--.-• x = CO
II-
=
MEDCOM - 19642
DOD-033216
RAPIDPOINI COAG ANALYZER V4., SERIAL. 09/30/03 06:10 AM
Patient ID: IIIII
0,) Test Name :PT Test Result: , 17.6 sec. ***RESULT NOT RANGE CHECKED*** Ratio = 1.4 Calculated INR = 1.81 Sample' Type:citrated wh. blood
Test Date :09/30/03
Test Time :06:08 AM -
Card Lot :040302
Operator
RAPIDPOINT COAG ANALYZER V4.54
SERIAL 1111111 09/30/03 06:13 AM
Patient ID: 'est Name
VIII/
Test Result:= 46.2 sec. ***RESULT NOT RANGE CHECKED*** Sample Type:citrated wh. blood Test Date :09/30/03 Test Time :06:10 AM Card Lot :100208 Operator MCCARTER TDPOIN COAG ANALYZER V4.54
\ LAL 09/30/03 12 :10-
tient ID: T Name IP Test Result:= 17.4 sec. ***RESULT NOT RANGE CHECKED*** Ratio = 1.4 Calculated INR = 1.78 Sample Type:citrated wh. blood Test Date :09/30/03 Test Time—'112:09 AM Card Lot :040302 Operator
-\\ RAPIDPOiliiiii ANALYZER V4.54 \SERIAL 09/30/03 12:13 AM \,
Patienty:11111111
Test NaMe :APTT Test Result:= 48.5 sec . ***RESULT NOT RANGE CHECKED*** Sairole Type:citrated wh. blood Test Date :09/30/03 Test Time :12:11 AM Card Lot2:1 0208 Operator
COAG ANALYZE(. .54 09/30/03 10:55 AM
Patient. ID: 796 t/ Test. Name :PT Test Result:= 17.0 sec. ***RESULT NOT RANGE CHECKED*** Ratio -7, 1.4 Calculated INR = 1.71 Sample Type:citrated wh. blood Test Date :09/30/03 Test lime :10:53 AM Card Lot :040302 Operator
\oLa
RAPIDP0iiiiiii ANALYZER V4.54 SERIAL 09/30/03 10:57 AM
Patient ID: 796
\E.
Test Name -:APTI Test Result:. 33.4 sec. ***RESULT NOT RANGMECKED*** Sample Type:citrated wh. blood TOst Date :09/30/03 TeSt Time :10:55'AM r:IrdLot2:100208 1)erator
4.;:ff2
1G,
=.77:=7: PICCOLO
09/30/03
06:30 AM
REFERENCE RANGE:
MALE
PATIENT #:
BASIC ME1ABOLIC
DISC LOT
3203AA4
OPER #111111 #: 000
SERIAL, #:
GLU
116 73-118 MG/DL
BUN 9 7-22
MG/DL
CA++ 8.4
8.0-10.3 MG/DL
CRE
0.5* 0.8-1.2 MG/DL
NA+ . tiet i1128-145 MOVE
K+
4.9* 3.3-4.7 MMOVL
CL-
96* 98-108 MMOVL
tCO2 28 18-33
MMOt4
INST OC: OK
Cl-EM DC: OK
HEM 0 , LIP 0 , ICJ 1+
;-;
MEDCOM - 19643
DOD-033217
i-STAT EG7+
U).) Li
ll,
Pt Name:
Pt :
128 mmol /L
N.?
3.8 mmol/L
26 mmol/L
1.06 mmol /L
30
le•.,•1:1L
pirt
At
4=d3
PH
32.6 mmHg
PCO2
73 mmHg
P02
25 mmol/L
HCO3
1 mmol/L
EiEecf
gin*
96 %
*calculated
Sample Type.)
05:35
,010CT@S• s
°Per: 11111 \-\ UY
Physician:
Ser#
Yer: 111111111
PPTNT CANCELLED **
AL
i-8TRT G3+
pt :
-
Pt Name:
Ten 29 rmmol/L
At 37C
pH 7.454
PCO2 39.0 mmHg
P02 76 mmHg
HCO3 27 mmol/L
BEecf 3 mmol/L
s02* 96 %
*calculated
At Patient Temp
PH 7.441
PCO2 40.6 mmHg
P02 81 mmHg
Patient Temp: 100.2F
FIO2 -45
Sample Type.)
pPINT CANCELLED **
PICCOLO ------
10/01/03
05:35 AM
REFERENCE MI
MA F.
PATIENT #:
BASIC METABOLIC
DISC LOU:
3203A A1
OPER #:
DR #: 000
SERIAL #:
GLU 110 73-118 MG/DL
BUN •s. 7-22 MG/D1_
CA++ 8.4 8.0-10.3 MG/DL
CRE 0.6 0.6-1.2 MG/CL
NA+ 4434428-145 MMUL
K+ 4.0 3.3-4.7 MMOVL
CL-92* 98-108 MOM_
tCO2 24 18-33 WOW
INST QC: OK CHEM OC: OK
HEM 0 , LIP 0 , ICT 14
MEDCOM 19644
-
DOD-033218
RAPIDPOINT COAG ANAL4ER V4.54
SERIAL #005485 10/0:03 12:52 PM
Patient ID.. R:,)-LI
Test Name :
Test Result:= 19.4 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1.6
.71Calculated INR = 2.12
Sample Type:citrated wh. blood
Test Date :10/01/03
Test Time :12:51 PM
Card Lot :040302
(A '
Operator2MUM
RAPIDPOINT COAG ANALYZER V4.54
SERIAL 0005485 10/01/03 12:55 PM
\
Pat tent ID11111'\-) I (ij- CI\
T Test Name :
Test Result:. 43.9 sec.
***RESULT NOT RANGE CHECKED***
Sample Type:citrated wh. blood
Test Date :10/01/03
Test Time :12:52 PM
Card Lot :100 f
-O \2
perator
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/01/03 05:29 AM
Patient IDUIV (Jk,._ Li Test Name :PT
Test Result:-: 18.5 Sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1.5
Calculated INR = 1.96
Sample Type:citrated wh. blood
Test Date :10/01/03
Test Time :05:27:AM
Card Lot :040302
Operator
RAPIDPOIK1 COAG ANALYZER V4.54
SERIAL #005485 10/01/03 05:33 AM
Patient IDIOM Test Name :APTT Test Result:= 38.6 sec. ***RESULT NOT RANGE CHECKED*** Sample Type:citrated wh. blood Test Date :10/01/03 Test Time :05:30 AM Card Lot :100208 1, -Operator
6 Am-4'M V4.fiJ
10/01/m 05:4 PM
Patient 1D: -
Test Name :PT
Test Result:= 26.9 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 2.2.
Calculated INR = 3.60
Sample Type:citrated wh. blood
Test Date :10/01/03
Test lime :05:43 PM
Card Lot :
Operator :
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/01/03 05:48 PM
Patient ( Lt) Test Name :APTT Test Result:= 43.1 sec. ***RESULT NOT RANGE CHECKED*** Sample Type:citrated wh. blood Test Date :10/01/03 Test Time :05:45 PM Card Lot :100208
01-1C43 17143 Pat**
Limits NC 18 1181/d. 4.5 10.5 RIC 3.701 :WWI 4.00 6.00 IPA 10.1 L 1/11.2ISA 1L0 Hct 32.2L Z235.0 11.0 ICY 07.2 Al2ILO 119
101 27.3 A227.0 31.0 IOC 31.3 L.213.0 Pit 657. H 1101/11. 150. 450. LU 14.1 *1. I220.5 51.1
1.1121.2* 1101/ti. 1.2 3.4
r 05W1
Patio*
Lisa'
111C 10.0 dr3Id. 4.5 115
RIC 3.511 210%/11. 4.00 1.6
to 4.51.
ILO ILI
ILA 30.91 I235.0 611
MCII 87.9 fl.2810 19.9
21.1 tt227.0 31.0
113C 319233.0 37.0
Pit 606. H 11V3hL 151 481.
LU14.6ILZ221551.1
LI 45*21.2 3.4
MEDCOM - 19645
RAPIDPOINT COAG-ANALYZER V4.54 SERIAL #005485 10/03/03 06:14 PM
Patient ID: 111111
Test Name :PT
Test Result:= 21.0 sec.
***RESULT NOT RANGE CHECKED*** Ratio = 1.7 Calculated INR = 2.41 Sample Type:citrated wh. blood Test Date :10/03/03 Test Time :06:12 PM Card Lot :lbw Operator : (
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/03/03 06:17 PM
Patient ID: \r-sD -Test Name :APTT Test Result:= 41.9 sec. ***RESULT NOT RANGE CHECKED*** Sample Type:citrated wh. blood Test Date :10/03/03
•Test Time :06:14 PM. Card Lot I , _ Operator
...
RAPIDPOINT COAG ANALYZER V4.54 SERIAL #0054135 10/03/03 04:19 AM
Patent ID: 01111
Test Name :PT
Test Result:= 18.6 sec.
* , *RESULT NUI RANGE CHECKED***
Ltio . 1.5
Lalculated INR = 1.98
:•amp?, Typc:citratffl oh blood
st Date. :10/03/03
lest lime :04:11 AM
Card Lot :01030
Operator :
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/03/03 04:22 AM
Patient ID:111111/, f \
Test Name
Test Result:= 37.7 sec.
***RESULT NOT RANGE CHECKED***
Sample Type:citrated wh. blood
Test Date :10/03/03
Test Time :04:19 AM
Card Lot :100
Operator
i. COAG ANALYZER V4.54 . :
:)485 10/03/03 12:45 PM
Patient ID: 111111/
Test Name :PT
Test Result:=, 20.0 sec..
***RESULT NOT RANGE CHECKED***
Ratio = 1.6
Calculated INR = 2.23
Sample Type:citrated wh. blood
Test Date :10/03/03 i
Test Time :la:43 PM
Card Lot :06,111
Operator :
•”! ,
RAPIDPOINT COAG ANALYZER V4.50
SERIAL #005485 10/03/03 12:48 PM
Patient ID: I (
Test Name :APT
Test Result:= 45.5 sec.
***RESULT NOT RANGE CHECKED***
Sample Type:citrated oh. blood
Test Date :10/03/03
Test Time :12:45 PM
Card Lot :100208
Operator :7 OM
am
03-10-03
03-10-03
as.18:14
Patio*
Patient
Limits
Limits
MIC 9.22x101/11.24.5 10.5
IBC 12.1 H x10'3/uL.
4.5 10.5
RIC 3.44 L e10"6/rt 4.00 6.00
RBC 3.84 L x10"6/uL 4.00 6.00
Hi 9.4L 9/d1.211.0 18.0
Hgb 10.3 L g/dL.
11.0 18.0
Ikt )).5 L Z235.0 60.0
Oct 33.6 L Z.
35.0 60.0
ILII 01.6200.0 99.9
MCV 87.5.80.0 99.9
fL.
ICH 27.3 ' pm227.0 31.0
ICH 27.0 L p9.
27.0 31.0
RD( 30.11 L233.0 37.0
IDC 30.8 L g/dL.
33.0 37.0
Plt 779. H z10"14. 150. 450.
Pit 829. H x10"3/uL 150. 450.
LYZ 27.0 Z 20.5 51.1
LYI 15.9 *1I.
20.5 51.1
Li 2.5 i101/eL 1.2 3.4
1.9 * x10"3/uL.ID: 111111203-10-03 MB.
LYN.1.2 3.4
12:40
Patient
Limits
IBC 10.1.4.5 10.5
x10"3/uL.
RBC 3.36 L 110"6/uL 4.00 6.00
Hgb.11.0 18.0
9.3 L g/d..
Hct 29.8 L I.
35.0 60.0
MCY 88.8.80.0 99.9
fl.
pg.
0 27.7 27.0 31.0
ncHc 31.2 L g/dL.
33.0 37:0
Pit 730. H x10"3/rd. 150. 450.
LYI 21.6 * I.
. 20.5 51.1
LYI.1.2 3.4
2.2 • 1:10'3/IL.
MEDCOM - 19646
DOD-033220
It: fill
02-10-03
02-10-43
22:23
PatientPatient
9.8
Liuits
110141. 4.5 10.5
NC 9.5 11414 4.5 10.5
RIC 3.75 1. 110`641. 4.00 6.00
RIC 3.56 I. 11101/eL 4.00 Rib 10.21
Wet2
11.0 ILO
I* 9.7 1. pit2Oct 32.9 I.
1140 MC/ 1235.0 60.0
Id 31.0 L 1235.0 60.0 ICY 87.7 t2
ELO 99.9
ID 87.2 11.280.0 PAS EN 27.2
n2
27.0 31.0
1131 27.32PI 27.0 31.0 IOC 31. 0 L it2
33.0 37.0
113C 31.3 L 33.0 37.0 Pit 792. If
drut 133. 450.
Plt 702. H 14014L 150. 450. LIZ 14.6 4.2
23.5 51.1
LY1 22.3 • 1 20.5 51.1
1.8 * x10141. 1.2 3.4
LI 2.1 • z10"3/t 1.2 14 02-10-03
91 WI202-1043
ri 17147
COS Patient
Patient Limit
Units IIC 11.0 H s101,111. 4.5 10.5 NC 9.3 a101/IL 4.5 10.5
111: 3.99 L x1014/1 COD RIC 3.63 slOWIL 4.00 IA. 1116 10.5 L IAL ILI ILO Iib 9.7 L2ILO I" 1kt 34.21 2235.0 Id 31.611235.060.0
ILII 17.9 I2IN LI IL213.0 99.9
ILO ff.! mi 27.91h227.0 31.0 101 26.1 L n 27.0 31.0 10C 30.7I. lit2ILO 37.0 ICC 30.11 L aftl233.0 37.0 Plt 195. H 1101M. 150. 450. Pit 736. H 110"3/IL 130. 450.
20.5 511
L1I14.3t1 20.5 51.1 LYZ 19.0 •I I2LI 1.6 •ain't L2, 14 LYI21.0 • x10'3/81. ... 1.2 3.4
2PICCOLO 2 10/02/032
0 4 : 1 3 AM REFERENCE RANGE:2
MALE PATIENT #111111., \,) t
, BASIC NETAB=2(-&- 2) DISC LOT #:23203AA4 OPER #:111112
DR #: 000 SERIAL #:
)U,L)
GLU 135* 73-118 MG/DL BUN25* 7-222MG/DLCA++ 8,52
8.0-10.3 MG/DL CRE 0.9 0,8-1.2 MG/DL
NA4 tIB*06q28-145 MOM_
K+ 4.5 3.3-4.7 MMIN/L
CL-
95* 98-108
MOM_ tCO2 23 18-332
MMUL
INST CC: OK
CHEM CC: OK
HEM 0 , LIP 0 , ICT 0
MEDCOM - 19647
RAPIDPOTNT COAG V4.54
SERIAL 0005485 10/02/03 03:47 AM (MAG ANALYZER V4.54
-.-o5485 10/02/03 11:22 AM
Patient ID: UM ( Lt) LI
Test Name :PT
Patient. ID:
Test Result:- 21.0 sec. Name 111/
***RESULT NOT RANGE CHECKED***
Tel Result:= 21.5 sec.
Ratio = 1.7
***RESULT MDI RANGE CHECKED***
Ratio - 1.8
Calculated INR = 2.41
Sample Type:citrated wh. blood Calculated INR = 2.50
Sample Type:citrated wh. blood
Test Date :10/02/03
Test Date :10/02g3
lest Time :03:45 AM
Niest Time :11:21 AM
Card Lot :040302
Card Lot
Operator )
Operator
RAPIDPOIN1 COAG ANALYZER V4.54
RARIDPuINT COAG ANALYZER V4.54
• SERIAL 0005485 10/02/03 03:51 AM
SERIAL #005485 10/02/03 11:25 AM
L c.c)
Patent ID
Patient ID:11. \r,) Lk )-
Test Name :APTT
4 Test Name • •
Test Result:= 39.7 sec.
***RESULT NOT RANGE CHECKED***
Test Result:= 39.3 sec.
Sample Type:citrated wh. blood ***RESULT NO1 RANGE CHECKED***
Test Date :10/02/03 Sample Type:citrated wh. blood
Test Date :10/02/03
Test Iime :03:47 AM
Test Time :11:23 AM
Card Lot :10 08
Lot :100208
Operator
b(b)
COAG ANALYZER Y4.54
0005485 10/02/03 10:24 PM
RAPiPOINT COAG ANALYZER V4,54
iient ID: III .\\- El
SERIAL 0005485 10/02/03 05:51 PM (12
Test Name. :PT
lest Result:= 19.4 sec.
Patient ID:
***RESULT NOT RANGE CHECKED***
Test Nameall
Ratio = 1.6
Test Result:. 20.9 sec.
***RESULT NOT RANGE CHECKED***
Sample Typecltrated wh. blood
Ratio = 1.7
Test Date :10/02/03
Calculated INR = 2.39
Test Time 40:23 PM
Sample Type:citrated wh. blood
Card Lot :010301
Test Date :10/02/03
Operator
Test Time :05:49 PM
Card Lot :010
Operator
RAPIDPOINT COAG ANALYZER V4.54
SERIAL 0005485 10/02/03 10:28 PM
RAPIDPOINT COAG ANALYZER V4,54
Patient ID:1111111 VD 11 (A) -
SERIAL 0005485 10/02/03 05:55 PM
Test Name :APTT
Test Result:= 33.9 sec.
Patient ID:
**RESULT NOT RANGE CHECKED***
:Test Name :APTT
Sample Type:citrated wh. blood
Test Result:= 40.9 sec.
Test Date :10/02/03
***RESULT NOT RANGE CHECKED***
Test Time :10:25 PM
Sample Type:citrated wh. blood
Card Lot :100
Test Date :10/02/03
Test Time :05:51 PM
Card Lot :100208
11111111111111p\
MEDCOM - 19648
L.
DOD-033222
ANALYZER v4.54
RAPIDPOINT COAG ANALYZER V4.54
!k; rj , :) 465 ' 4/03 01 :b5 PM
SERIAL 11005465 10/04/03 06:14 AM (C.C.) -LI Patient ID: 1111. \=,, Lb) Ld
Patient 11111
Test Name :PT ,
Test Name : T
Test Result:. 19.:3 sec.
Test Result:= 16.4 sec.
***RESULT NOT RANGE CH(CKED***
***RESULT NOT RANGE CHECKED***
Patio = 1.6
Ratio = 1.3
Calculated INR = 2.10
Calculated TNR = 1.61
Sample Type:citrated wh. blood
Sample Type:citrated wh. blood
Test Date :10/04V03
Test Date :10/04/03
Test Time :01:53 PM
Test Time :06.:12 AM
Card .Lot_ :010301
Card Lot :010301
) Operator 1 ( (.4)-
Operator :1111111((.z
RAPIDPOINT COAG ANALYZER V4.54
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/04/03 01:59 PM
SERIAL 11005465 10/04/03 06:16 AM
Patient. ID:' (
Patient ID:111111
Test Name :APTT
Test Name :APTT
Test Result-:= 35.0 sec.
Test Result:= 32.Q sec.
***RESULT NOT RANGE CHECKED***
***RESULT NOT RAW CHECKED***
Sample Type:citrated wh. blood
Sample Type:citrated wh. blood
Test Date :10/04/03
Test Date :10/04/03
Test Time :01:55 PM
Test Time :06:14 AM
W :100208
Card Lot :100208
oprki:H
Operator
ID: 11111
04-10-03
ID: 111111
06:12 04-10-03
ID: 1111111
Patient NB 04-10-03
13:56
118
Limits 17:50
Patient
RC 12.4 H x10'3/111. 4.5 10.5 Patient
RBC Limits
3.91 L x10"6/u1 4.00 Limits
6.00 MEWx10"3/il1 4.5 10.5
Hgb 10.6 L g/d1 11.0 18.0 WIC 11.6 H :10'3/k 4.5 10.5
x10'6/u1 440 6.00
Hct 34.3 L X 35.0 60.0 g/dL Putt' 4.13 x10'6/uL 4.00 6.00
tICV 87.7 11.0 18.0
11 ao.q Hgb 11.2 g/dL 11.0 18.0
35.0 60.0
INS 27.1PPg 99.9 35.9 Z 35.0 60.0
27.0 31.0 XV N.1 ft
80.0 99.9
YIN 30.9 gldl 33.0 37.0 ID 27.4 pg MCV :..9 fL 80.0 94.9
PIt 27.0 31.0
478. * x10"3/al 150. MCH 27.2 Pg227.0 31.0
LT 450. Inisomg/dL 33.0 37.0
18.1 *t X XX 31.3 L g/dL 33.0 37.0
20.5 51.1 Pit 837. H
LYN 2.2 :10"3/uL 150. 450.
* x10"341. Plt 796. H x10`3/ul 150. 450.
1.2 3.4 LYZ 16.9 *t X 20.5 51.1
LYZ 15.5 *L X 20.5 51.1
LYM 2.1 * x10"3/u1
1.2 3.4
LYM 1.8 * x10"3/aL 1.2 3.4
MEDCOM - 19649
05-10-03
ID:
04:19
ID:111111 05-10-03
Patient WB 00:53
Limits
Patient
UBC 12.9 H x10"3/ilL 4.5 10.5
Limits
RBC 3.46 L x10"6/uL 4.00 6.00
WIC 13.8 H x10"3/ilL 4.5 10.5
Hgb 9.4 L g/dL 11.0 18.0
RBC 3.59 L x10"6/aL 4.00 6.00
35.0 60.0
Hct 30.2 L %
Hgb _ 9.9 L g/dL 11.0 18.0
fL 80.0 99.9
MCV 87.4
Hct 31.3 L X 35.0 60.0
27.0 31.0
MCH 27.3 pg
MCV 87.1 fL 80.0 99.9
OE 31.2 L g/dL 33.0 37.0
NCH 27.6 pg 27.0 31.0 '
Pit, 849. .H 00"3/uL 150. 450.
MONC 31.7 L g/dL 35.0 37.0
07'17.4 *4_ X 20.5 51.1
Pit 861. H x10"3/uL 150. 450.
LYN 2.2 * x10"3/ML 1.2 3.4
LYI 14.5 *L X 20.5 51.1 LYN 2.0 * x10"3/uL 1.2 3.4
6710-03
ID: 05-10-03
17:02
12:34
WB
Patient
Limits
••• Patient
Limits
4.5 10.5
WIC 10.2 x10"3/td. 4.5 10.5 WBC 12.3 H x10"3/ilL
RIC 3.20 L x10"6/mL 4.00 6.00 x10"6/ML 4.00 6.00
RBC 3.92 L Hgb 8.7 L g/d1 11.0 18.0 Hgb 10.8 L g/dL 11.0 18.0 Hct 27.8 L X 35.0 60.0 35.0 60.0
Hct 34.7 L %
80.0 99.9
NCV 86.9 fl 90.0 99.9 fL
MCV 88.5
10 27.3 pg 27.0 31.0 pg 27.0 31.0
MN 27.5
-33.0 37.0
Mt 31.4 L 33.0 31.0
MCHC 31.1 L
Pit 799. H x10"3/uL 150. 450. Pit 973. H x10"3/ilL 150. 450.
LYX 20,0 *I X 20.5 51.1 LT% 19.7 *I. % 20.5 51.1
LYN 2.0 * x 10 '3/ul_ 1.2 3.4 2.4 * x10"3/ilL 1.2 3.4
LIN
ID: 11111 05-10-03
48 23:35
Patient
Limits
WBC 10.3 x10"3/uL 4.5 10.5
RBC 3.52 L x10"6/uL 4.00 6.00 Hgb 9.7 L g/dL 11.0 18.0 Hct 30.9 L X 35.0 60.0. MCV 87.8 fL 80.0 99.9 MCH 27.6 pg 27.0 31.0 MCHC 31.4 L g/dL 33.0 37.0 Pit :42. H x10"3/ilL 150. 450. LY% 24.3 * X 20.5 51.1 LYN 2.5 * 7.10"3/uL 1.2 3.4
•
MEDCOM - 19650
DOD-033224
RAPIDPOINT COAG ANALYZER V4.54 WAG ANALYZER V4.54
SERIAL #005485 10/05/03 04:47 :,7.185 10/05/03 00:57
Patient ID: WO Patient IDIOM
Test Name :PT Test Name :PT
lest Result::. 17.1 sec. Test Result := 18.8 sec.
***RESULT NOT RANGE CHECKED*** ***RESULT NOT RANGE CHECKED***
Ratio = 1.4 Ratio = 1.5
Calculated INR = 1.73 Calculated INR = 2.01
Sample Type:citrated wh. blood Sample Type:citrated wh. blood
Test Dote :10/05/03 Test Date :10/05/03
Test Time :04:46 lest Time :00:55
Card Lot :010301 Lard tot :010301
Opelator 1111111111111 Operator) IMO
RAPIDPOINT COAG ANALYZER V4.54 RAP1OPO1NT COAG ANALYZER V4.54
SERIAL #005485 10/05/03___04:51 . _SERIAL #005485 10/05/03 01:00
Patient ID: Patient ID:
Test Name :APTT Test Name !"
Test Result:= 30.9 sec. Test Result:= 36.6 sec.
***RESULT NOT RANGE CHECKED*** ***RESULT NOT RANGE CHECKED***
Sample Type:citrated wh. blood Sample Type:citrated wh. blood
Test Date :10/05/03 Test Date :10/05/03
Test Time :04:47 Test Time :00:57
Card Lot :100208 Card l(711-:100208
Operator :1111.11111
H...LYZER V4.54 ILft
vAPIDPOINT COAG ANALYZE'-
VO:y.,-ILLt to/05/03 12:35 `t. ,1/11
SERIAL #005485 10/05/0J
Patient ID: Patient ID: ;(6,)-
Patient
Test Name : T TeSt NaMe :PT
Test Name :PT
Test Result:= 18.9 sec. Test Result:= 17.5 sec.
Test Result:=• 17.4 sec.
***RESULT NOT RANGE CHECKED*** ***RESULT NOT RANGE CHECKED***
***RESULT NOT RANGE CHECKED***
Ratio = 1.5 Ratio = 1.4
Ratio = 1.4
Calculated INR = 2.03 Calculated INR = 1.79
Calculated INR = 1.78
Sample Type:citrated wh. blood Sample Type:citrated wh. blood
Sample Type:citrated wh. blood
Test Date :10/05/03 Test Date :10/05/03
Test Date :10/05/03
Test Time :12:33 Test Time :16:55
Test TiMe :23:35
Card Lot :010301 Card Lot :010301
Card Lot :010301
Operator 1111111111 Operator
Operator
\cm
4 )IDPOINT COAG ANALYZER V4.54 RAPIDPOINT COAG ANALYZER V4.54
RAPIDPOINT COAG ANALYZER V4.54
3ERIAL, #005485 10/05/03 12:38 SERIAL #005485 10/05/03 17:03
SERIAL #005485 10/05/03 23:40
t I
'atient ID: Patient ID1111
Patient
Test Name Test Name :
Test Name :APTT
Test Result:= 31.4 sec. Test Result:= 28.4 sec.
Test Result:= 32.5 sec.
***RESULT NOT RANGE CHECKED*** ***RESULT NOT RANGE CHECKED***
ESULT NOT RANGE CHECKED***
Sample Type:citrated"wh. blood Sample Type:citrated wh. blood
Ye Type:citrated wh:Olbod
Test Date :10/05/03 Test Date :10/05/03
Date :10/05/03 f4. ;
Test Time :12:36 Test Time :17:00
Ririe :23:38
Card Lot :100208 Card Lot :100208
Card-Lot :100208
Operator Operator
Operator MEP
111111111k,
----• -- •
MEDCOM 19651
-
04)-10-03
15: 1111
16:39
3:111, 06-10-03
06-10-03
VB 11:14 Patient
22:47
Patient WB Limits
Patient
Limits 11.6 H 110'.3/uL 4.5 10.5
Limits WBC
WBC 11.0 H x10"3/uL 4.5 10.5 110"6/uL 4.00 6.00 •
11.2 H x10"3.411. 4.5 10.5 RDC 4.07
PIC 3.64 L x10"6/uL 4.00 6.00 WBC 11.0 18.0
11.1 g/dL
RBC 4.09 x10"6/uL 4.00 6.0* Hgb 60.0
Hgb 9.8 L g/di. 11.0 18.0 % 35.0
g/dL 11.0 18.0 Ht% 35.5
Hct 31.8 L Z 35.0 60.0 ligh 11.1 87.3 fL 80.0 99.9
35.0 60.0 MCV
35.5 % 31.0
MCV 87.3 ft 80.0 99.9 Hct 27.0
fL 80.0 99.9 rcH 27.2 pg -
MCH 27.0 L 27.0 31.0 ncv 86.9 33.0 37.0
PS MCHC 31.2 L g/dL
27.0 31.0
27.1 pg 450.
MHC 30.9 L g/dL 33.0 37.0 MCH 1G38. +H x10"3!uL 150.
01 33.0 37.0 Flt
Pit 889. H.x10"3/uL 155. 450. 1ICHC 31.1 L * % 20.5 51.1
1083. +H x10"3/11 150. 450. Li% 23.5 3.4
LY% 23.1 * % 20.5 51.1 Pit 2.7 * x10'3/dL 1.2
20.5 51.1 Lig
Lig 2.5 * x10'3/u1 1.2 3.4 Li% 24.8 * %
* x1043/1iL 1:2 3.4
Lig: 2.8
Repe
06 -10-03
06-10-03
IP:.all ID: 111111111
17:51
04137 VB
6$
Patient
Patient
Limits
Limits
WBC 9.8 x10"3/UL 4.5 10.5 WC 9.7 x10'3/uL 4.5 10.5
4.00 -6,00
RBC . 3.54 L x10"6/uL 4.00 6.00 RBC 3.62 L x10'6'uL
-Hgb 7.7 L g/dL 11,0 18.0 Hgb 10.0 L g/ d1 11.0 18.0
35.0 60.0
Hct 30.9 L X 35.0 60.0 Hct 31.7 L X '
fL 80.0 99.9
MCV 87.4 fL 90.0 99.9 to 86.0
27.0 31.0
MCH 27.3 pg 27.0 31.0 MCH 27.1 pg
11CHC 31.3 L g/dL 33.0 37.0 rm3 31.5 L g/dL 33.0 37.0
Pit 904. H x10"3/uL 150. 450. Pit 900. H x10"3/uL 150. 450.
% 20.5 51.1
LYX 26.9 * % 20.5 51.1 Li% 21.1 *
3.4;
LY# 2.6 * x10"3/uL 1.2 3.4 LY# 2.0 * Y10'3/uL 1.2
PICCOLO -------
10/06/03 05:11
REFERENCE Rliily'{MALE
PATIENT #:
METLYTE 8
DISC LOT #: 3141AA4
OPER #: DR #: 000
SERIAL
GLU 109 73-118 MG/DL
BUN 8 7-22 MG/DL
CRE ;0.6 0.6-1.2 MG/DL
CK 156 39-380 U/L
NA+ wW.131 1 28-1 45 MMOVL
K+ 4.3 3.3-4.7 MMOVL
CL-97* 98-108 MMOL'L
tCO2 19 18-33 MMOL'L
INST OCi OK CHEM Cr: OK
HEM 0 LIP 0 1CT 0
MEDCOM - 19652
DOD-033226
RAPIDPOINT COAG ANALYZER V4.54
.
SERIAL #005485 10/06/0
16:32
Patient .D1 jj--Test Name SPT Test Result:= 17.4 sec. Ratio = 1.4 Calculated INR
Sample Type:citrated wh. blood
Test Date :10/06/03
TeSt Time :16:30
Card Lot
:010301
Operator :11111111--
)
RAPIDPOINT COAG
ANALYZER V4.54
SERIAL #005485 10/06/03 16:35
•
I Patient ID: L Test Name Test Result:= 27.2 sec. ***RESULT OUT OW, RANGE*** Sample Type:citrated wh. blood
Test Date :10/06/03
Test Time :16:33
Card Lot :100208
Operator
RAPIDPONI COAG! A V4.54
SERIAL #1)0A85 -11.7/06/03 22:49
Patient I
;PI
Test Nam :PT
Test Result:= 16.4 sec.
Ratio 1.3
Calculated INR =
Sample Type:citrated wh. blood
Test Date :10/06/03
Test Time :22:47
Card Lot :0103
Operator ,
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/06/03 22:53
Patient ID:
Test Name :APTT
Test Result:= 24.3 sec.
***RESULT OUT OF RANGE***
Sample Type':citrated wh. blood
Test Date :10/06/03
Test Time :22:50
Cart) Lot :1002
Operator
.........
... ....
.2,0AG ANALYZER V4.54
='85 10/06/03 11:16
Patient 10:1111111
Test Name :PT
Test Result:. 17.2 sec.
Ratio = 1.4
Calculated INR = 1.74
Sample Type:citrated wh. blood
Test Date. :10/06/03
Test Time . :11:14
Card Lot
Operator :
RAPIDPOINT COAG ANALYZER V4,54
SERIAL #005485 10/06/03 11:19
,Th
Patient. ID:111111
Test Name :APTT
Test Result:= 31.8 sec.
SoNiple Type:citrated wh. blood
lEA Date :10/06/03
( Lt Time :11:16
Ci, :d Lot
1DPOINT CD G ANALYZER VC54---
11AL #005485 10/06/03 04:40
ent ID:
lest Namellill
Test Result:. 16.2 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1.3
Calculated INR = 1.58
Sample Type:citrated wh. blood
Test Date :10/06/03
Test Time :04:39
Card Lot :0
Operator
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005485 10/06/03 04:46
Patient ID:
Test Name :APTT
Test Result:= 34.1 sec.
***RESULT NOT RANGE CHECKED***
Sample Type:citrated wh. blood
Test Date :10/06/03
Test Time :04:41
rfill HI :10
.1
—
MEDCOM - 19653
DOD-033227
RAPIDPOINT COAG ANALYZER V4.54
SERIAL #005465 10/07/03. 0424
Patient ID: (
)-
111
Test Name 141111
Test Result:=
Ratio = 1.3
Calculated INR = 1.58
Sample Type:citrated wh. blood
Test Date :10/07/03
04a
Test Time :04:22
Prelt1
Card Lot ;010301
Liits
Operator 1
xinjuL 4.5 If).5
10100!WrIO AMi 4.0r) EhM
400 103/(11. 11.0
RAPIDPOINT COAG ANALYZER V4.54
OV 87.6 t 0.0
SERIAL 11005485 10/07/03 04:26
1 27.4 n 27.0 31.0 1 \ 4.?..6gAL 33.0 37.0
Patient ID:
r..414--9744. H x10'3/11 150. d. Test Namelliiii -; j DI 20.7 * % Test Result:= 30.3 sec. UT 14 x10'3.111 20.5 5.71:„.,11 Sample Type:citrated wh. blood Test Date :10/07/03 Test Time :04:24 Card Lot :100208
Operator ------- PICCOLO ===L===
. 07/10/03
04:06
REFERENCE RANGE:
MALE
PATIENT #:
METLYTE 8
DISC LOT
OPER #:
DR #: 000
SERIAL #:
X
.............
GLU 108
. .... .
73-118 MG/DL
BUN 8
7-22
MG/DL
• CRE 0.8
0.6-1.2 MG/DL1
CK 111
39-380 U/L
NA+
11.-01-WdAi28-145
MMOtL
K+ 4.8* 3.3-4.7 MMOtt_
CL-98
98-108 MMOI/L
tCO2 20 18-33 MMO&L
INST OC: OK
CHEM OC: OK
HEM 0 LIP O, ICT 0
15-10-03
11:19 Patient
Limits IRE 9.0 it101/11. 4.5 10.5RE 4.17 i10"6/IL 4.00 6.00 Hgb 11.2211.0 110 lict B.1260.0
86.5 fi.ILO 59.9 ICI 26.91 pg227.0 31.0 WiIC 3L1L9It233.0 37.0
Pit 560. H 1109/d. 150. CO. LYZ 25.3 1 .551.1 LYI 2.3 i101/.1. 1.2 3.4
MEDCOM - 19654
DOD-0 3 32 2 8
SPECIMEN TAKEN
TIME / /4°. P.M.
REQUESTED
k))
19-0C-03
11:45 Patent
Li.its
WBC 13.9 H x10"3/uL 4.5 10.5 R 3.71 I x10h6/uL 4.00 6.00 Hab 10.5 L. AL 11.0 18.0 Hct 32.8 L X 35.0 60.0 HD 88.3 fL 80.0 99.9 HCH 28.22pg 27.0 31.0
V& 31.92gidl 33.0 37.0 it 163. Y.10'31d. 150. 450. ' LY 16.1 *L X 20.5 51.1 LY 2.2 * x10'3/61,. 1.2 - 3.4
'7•••••¦••••¦ .
VISMANECNS. ••
fiGAM 5.17•R... 3,771'
,Prmr*loel by GbAwCall .
,-1112144111 Cflt} 20145A05
PATIENT'S MED. RECORD
I2I
MEDCOM - 19655
DOD-033229
Q
TEST(S) SPECIMEN TAKEN
RESULTS
0
z
z
I:1
57
0
g iD
5 z
MISCELLANEOUS 557-107
STANDARD FORM 557 !RR. 3-771
1,eur5,ed by GSA/IC/Mt
FERMI2Cf RI 201-45-505
PATIENTS MED. RECORD
U .1.
1.
It: •
ID:P
04-10-03
MB
00:36 Patient
Limits UK 11.8 H x10"3/u1 4.5 10.5 RBC 3.651 x10"6/u1 4.00 6.00 Hgb 9.9 1 g/dL 11.0 18.0 Hct 32.1 I. X 35.0 60.0 YIN 88.0 H. 80.0 99.9 PDI 27.1 pg 27.0 31.0 IOC 30.8 L g/dL 33.0 37.0 Pit 827. H x10"3/n1 150. 450. LYX 17.6 *L X 20.5 51.1 LYN 2.1 * x10"3/eL 1.2 3.4
AH0 31S0d3 illOYdONLLY
RAPIOPOINT COAG ANALYZER V4.54
; SERIAL #005485 10/04/03 12:39 AM
Patient ID: 111111
Test Name :PT
Test Result:= 17.3 sec.
***RESULT NOT RANGE CHECKED***
Ratio = 1,4
Calculated INR = 1.76
Sample Type:citrated wh. blood
Test Date :10/04/03
Test Time :12:37 AM
Card Lot :010301
Operator
-
C'e\)
INN ! CUAG ANALYZER V4,54 ',.,thiAL 4005485 10/04/03 12:53 AM
IMO
Patient ID:
Test Name :APTT
Test Result:= 33.1 sec.
***RESULT NOT RANGE CHECKED***
2 Sample Type:citrated wh. blood Test Date :10/04/03
Test Time :12:50 AM
Card Lot :100208
•
P nqrrator
II
MEDCOM - 19656
-P
TESTIS)
SPECIMEN TAKEN
23
DATE rimE —1
cr 2-12
z
REQU STED 0 F
-,§
OL,
RESULTS
H
cn
0
5
114 Z
r¦
PcD2
0
z
rn
itos 5a0z -T) or
ABa3taiod
=4
z
0
-1P7F1 7C z
111
°7- 33.5
F20-1, 51
5
•
MISCELLANEOUS 557-107 0
STANDARD FORM 537 Rey. 3-77)
Presaibed by GSA/)CMR
Tn
CFR) 201-43-305
I 1 . PATIENT'S MED. RECORD
ON'Ida EIV11N3WID1dS
MEDCOM - 19657
DOD-033231
TESTIS)
- •
-
= PICCOLO z
OLo - - - - "
s anoqo u! 4e4u3
21/09/03 0 0
04:3G
rn
rn
REFERfNCE RA
• m
MALE
PAIIEN4
BASIC MCIABOLIC 9a) 0
MSC LOT #: z
3203AA4
OPEP #: 111111„/UDR #: 000
z
SERIAL #'
C)
GLU 119* 73n
-4
-118 W:LL
-
Mt:N-0-H- 7-22 . MG/DL
CA+' 7.8* 8.0-10.3 MG/DL 0
ORE 0.9 0.1- M6/11 '0z
NA,
1 12A-115 IstiOtt O I
K+ .
3.9 3.3-1.7 MOM_
CL -100
98.108 MMCF
tCO2 27 18-33
MOM_
. .-4 5
m0200
INST OC: OK CHEM OL: OK c.,, m y 0 Hal 0 , LIP 0 , ICI 0 m m
m, -°
u d D 0 7.
Z 0 CD
f" -I
i—NOLLVDIJI/
§
Z
'V
z
Z
—4 a
...rn MISCELLANEOUS25$7-101 .. 0'7
0 W STANDARD /ORM 30 (Re, 3-771 Proaerbed by GSA/KMR FIRMR 41 Cal 701-45-505 z: 0 .
PATIENTS MED. ItORIT-. PATIENTS MED. MOW_
MEDCOM - 19658
DOD-033232
Ward/Section:2.ttAi REQUESTIN2N:2N CHEMISTRY RESULT FORM
TEST I RESULT REF: RANGE
138-146 nunol/dL
Na
3.5-4.9 mmol/L
98-109 mmol/L
pH 731-7.45
PCO2 35-45 nunlig (art)41-51 mmHg (yen) PO2 80-105 mmHg (art) N/A (yen) 23-27 mmol/L (art)
TCO2
24-29 mmol/L (yen) HCO3 SO2 95-98% BEecf (-2) - (+3)
mmol/L
AnGap 10-20 mmol/L
Ca 1.12-1.32 mmol/L
BUN 8-26 mg/dl
GLU 70-105 mg/dI
Creat 0.7-1.5 mg/dl
Hct 38-51% PO/
Hgb 12-17 01
Ami
.-4:004ost006,K4ftfibti
TEST RESULT REF RANGE
Tropoin-1
Drug of Abuse
REMARKS:
VI
REP2:2
ALB
AL1'
ALT
AMY
AST
TBIL
BUN
CA. +4-
CHOL
CRE
GLU
T1' etti4
TEST
GLU
BUN
CRE
CK
NA+
K+
CL
tCO2
DATE:
cr.\
b(¦ -DATE
IrOv/7
3.5-5.5 g/dI 26-84 u/I 10-47 u/I 14-97 u/I
11-38 u/I
0.2-1.6 mg/di 7-22 mg/d1 8.0-10.3 mg/dl 100-200 mg/dI
0.6-1.2 mg/d1 73-118 mg/dI 6.4-8.1 01
solmitt.e 4 liabwale.; RESULT REE RANGE 73-118 mg/di
7-22 mg/dl 0.6-1.2 mg/dl 39-380 /I (M)
30-190 /I (F) 128-145 mmol/1
. 3.3-4.7 mmol/1
98-108 mmo1/1
18-33 mmol/1
g' ! i • 141:13
LAB ID NO.:
(Subject to the Privacy Act of 1974)
7=1-7 PICCOLO
06/10/03
16:19
REFERENCE RANGE:
MALE
PATIENT #: 6 (4) -c-i
BASIC METABOLIC
DISC LOT #:
320.3AA4
OPER #:
DR #: 000
SERIAL
GLU 129* 73-118 MG/DL
BUN 7 7-22 MG/DL
CA++ 8.4 8.0-10.3 MG/DL
CRE 0.6 0.6-1.2 MG/DL
NA+ •.• 128-145 MMOVL
K+ 4.4 3.3-4.7 MOM.
CL-97* 98-108 MMOVL
tCO2 21 18-33 MMOVL
INST QC: OK CHEM QC: OK
HEM 0, LIP O, ICT 0
7-50
AM — / D
1CO2 18-33 mmol/1 •
MEDCOM - 19659
DOD-033233
--.2-
W1,014066'9 • RE 02 CHEMISTRY RESULT FORM
(Subject to the Privacy Act of 1974) —
SSN/PEEUDO SSN:
D
gefug '''.c.. , ,z,.... ;, .., ' 0-„lift)* 24: ,,,2t ,,. 02' C Rio 3^„,e
„..„. ..,,,
.,,:tvr,,,o vt. ie4.,,u *4 '''4'' ,2Ar '*‘ 1 2'7'.2,-,''''Or';,ZAW,2`, s' k3402 •L2' , -sN-,1 2-.:0.'"''2-4e-
RESULT .REF RANGE
TEST RESULT REF RANGE .TEST .RESULT .REF TEST
RANGE
138-146 nurioUdL2ALB2 3.5-5.5 g/d1 73-118 mg/d1
Na GLU2
.i 36
ALP2 26-84 u/1 7-22 mg/d1
K 3.5-4.9 Imola.,2BUN2
.3-/
8.0-10.3 Ing/d1
98-109 mmol/L2ALT2 10-47 u/1 CA++2
210 I 0.6-1.2 mg/di
pH 7 _ c(LG 7.31-7.452AMY2 14-97 u/1 CRE2
128-145 mrnol/dI
,_ 35-45 mmHg (art)2AST2 11-38 u/I NA+2
PCO2
33 . ..-41-51 nunlig (ven)
P02 80-105 mmHg (art)2TBIL2 0.2-1.6 mg/d1 K+23347 nunolll
N/A (ven)
TCO2 ,...-23-27 nunoUL (art) BUN 7-22 mg/t11 Cr2 98-108 mmolII
,P.5 24-29 mmoUL (ven) , L 22-26 minoUL (art)28.0-10.3 mg/d1 18-33 mmol/1
HCO3 CA++2 tCO2
r 1 23-28 mmol/L (art)
SO2 95-98%2CHOL2 100-200 mg/d1 ...6.#,2)t.c.50#.,.,, 2, .: P4 :,, t04:144
BEecf (-2) - (+3) CRE 0.6-1.2 mg/dl TEST .RESULT .REF RANGE
6 nunoUL2
73-118 mg/dl ALB2 3.3-5.5 g/d1
AnGa p 10-20 mmoUL
f ci
26-84 u/11.12-1.32 nunoUL2TP 2 1 gill
Ca
.,.. • ...,
41. 0; + "'''''''' ALT2 10-47 oil
'''. 1. ''
BUN 8-26 mg/d12
C"( , n
70-105 mg/dl2 RESULT .REF. AST2 14-97 u/1
GLU
I .?./ RANGE
73-118 mg/di AN Y2 11-38 u/I
Creat 0.7-1.5 mg/d12GLU2
OM 7-22 mg/dl TBIL2 0.2-1.6 mg/dl
Hct 38-51% PCV2BUN2
.35^
0.6-1.2 mg/d1 5-65 u/I
Hgb 1 a. 12-17 Wdi2CRE2
.. . .
39-380 /I (M) 6.4-8.1 g/d1
-.4041. ;,,2, 2(..c, , 13 204 , IN CK
30-1N /1(F)
,,.„2 REE RANGE .NA+ 128-145 mmol/1 rtjad 0.2I/*IA2kff2'.. y.
;,TEST RESULT 4i.,;.i.” 2 4:3,, ,z-Lk, 2
3-34.7 mmo1/1 RESULT REF RANGE
Tropoin-1
Drug of CL2 98-108 nuno1/1 NA+ 128-145 mmol/1
Abuse
tCO22 18-33 mmollI K 3.3-4.7 mmol/1
CL- 98-108 mmol/1
1CO2 18-33 mrno1/1
REMARKS:Op.ic, 19.77/r.,--.ypiestff
REPORTED BY: I DATE: 1 LAB ID NO.:
ruiner-Inn _ 1 CIRRI-1
DOD-033234
,.‘
Ward/Section (2 RE2 CAN: CHEMISTRY RESULT FORM
V) ( C'---Z.-(Subject to the Privacy Act of 1974) A TIME SSN/PEEUDO SSN:
LAST, FIRST,MLAST
,2 ) -''',, L 4
fa 44320 •A.:',...%vx,, '" nkv e-, -,,), 10:016YOtiOfif: : -,,,,,,,,, tabu ODIC Pane
'.:1441t4H
-0 41,106„, rgotvoni ::, "s.. -K — AT:EkOfVFESIVA iA , ek4 '''.1: It'" e
''',
RESULT REE RANGE
TEST RESULT : REE RANGE TEST RESULT REF. TEST
RANGE
3.5-5.5 OH 73-118 mg/d1
2i?ec 138-146 mmol/dL ALB
Na GLU
7-22 Ing/d1431 7.-3.5-4.9 rrunoUL ALP 26-84 u/1
K BUN
8.0-10.3 ing/d1
Cl i. / 4, 98-109 mmol/L ALT 10-47 u/1 CA++
pH '7f y k 7.31-7.45 AMY 14-97 u/1 CRE 0.6-1.2 mg/di
PCO2 . , 35-45 mmHg (art) AST 11-38 u/I NA+ 128-145 moi/dl
It , 41-51 mmHg (ven)
P02 TBIL 0.2-1.6 mg/dl K+ 3.3-4.7 mmol./1
11,(//20(5voninplig (art)
I I Li-
BUN 7-22 mg/d1 Cc 98-108 mmol/i
TCO2 ac' 2119 mmol/[,(laZtnj7
2
18-33 mmo1/1azi, 2
32:2
68 inzrolilL 8.0-10.3 mg/t11 ico2
HCO3 CA++
a. (art)
ISC7 95-98% CHOL 100-200 mg/d1
SO2 ,s #E :
BEecf (2) - (+3) CRE 0.6-1.2 mg/dl TEST RESULT REF RANGE
( mmol/L GLU 73- 18 mg/d1 ALB 3.3-5.5 01
AnGap 10-20 nunoUL
26-84 u/1
Ca 1.12-1.32 mmol/L TP 6's ALP
BUN 8-26 mg/dl .,;,-?„2,if-'i,2— -2„2J-K, ALT 10-47 WI
..,...v,
'"
GLU 70-105 mg/d1 TEST ' REQ AST 14-97 u/I
'= 'GE
Creat 0.7-1.5 mg/d1 CLU 73-118 mg/d1 AMY 11-38 u/12"
7-22 mg/di -TBIL 0.2-1.6 mg/diHet 38-51 % PCV , BUN
i-9
0.6-1.2 mg/d1 GGT 5-65 u/I
Hgb 12-17 g/d1 CRE
/121
0V4ik oom.F.4, ' 39
412‘..s.„...z, ,.. ,,,,„ou,a....Ac — Itk:=4,2CK -380 /1 (m) TP 6.4-8.1 g/d1
30-190 /1 (F)
1.. .., . -.;,*?;..4‘,..., it.001,,tfA -AeziAt ?..
TEST RESULT REE RANGE NA+ 128-145 mmol'l top, igto
...,,,„-,:,....,, ..,,....,
,,,t,,,,,,„
K+ 3.3-4.7 mmol)[ TEST RESULT REF. RANGE
Tropoin-1
Drug of Cl; 98-108 mmol/1 NA+ 128-145 mmol/12' Abuse tCO2 18-33 mmol/I K+ 33-4.7 nunolil
Cr 98-108 mmol/1
tCO2 18-33 nuno1/1
REMARKS:
-2-
REPORTED BY:2I DATE: I LAB ID NO.:
MEDCOM 19661
-
DOD-033235
Ward/Section: TC (A-4. LAST, FIRST,M1.
CL
9'e VN
kZpb
TEST RESULT I REF: RANGE
Na 138-146 mmol/dL
K 3.5-4.9 mmoUL
98-109 mmol/L
pH 7.31-7.45
PCO2 35-45 mmHg (art) 41-51 mmHg (ven) P02 80-105 mmHg (art) N/A (yen) 23-27 mmol/L (art)
TCO2
24-29 mmoUL (yen) 22-26 nunol/L (art)
HCO3
23-28 mmol/L (art) SO2 95-98% BEc cf (-2) - (+3) mmoUL AnGap 10-20 mmol/L Ca 1.12-1.32 nunol/L BUN 8-26 mg/dl GLU 70-105 mg/dl
Creat 0.7-1.5 mg/dl Hct 38-51% PCV 118b 12-17 gAll
;s„...
rimismhuit
Awmpimmoftwor,
TEST RESULT - REF. RANGE
Tropoin-1
Drug of Abuse
REMARKS:
REPORTED BY:2
bM -
YSICAN:
DATE TIME d
'AK icco_
lo) Chemic
fi
4';giSg.
°
TEST RESULT REP: RANGE
ALB 3.5-5.5 01
26-84 u/1
ALP
ALT 10-47 u/I
AMY
14-97 oil
AST
11-38 u/I
TBIL 0.2-1.6 mg/di BUN 7-22 mg/di
+ 1-
CA8.0-10.3 mg/d1 CHOL 100-200 mg/dl CRE 0.6-1.2 mg/dl GLU 73-118 mg/dl TP 6.4-8.1 g/d1
;OP 4,
•••=t
Lh
3114in •
g whot%
TEST RESULT REF. RANGE
73-118 mg/ill
GLU
BUN 7-22 mg/dl
0.6-1.2 mg/dl
CRE
CK 39-380 /I (M)
30-190 /I (F)
NA+ 128-145 =non
3.3-4.7 nuno1/1
98-108 mmo
CL-tCO2 18-33 nunoVI
DATE: LAB ID NO.:
MEDCOM - 19662
CHEMISTRY RESULT FORM
(Subject to the Privacy Act of 1974)
SSN:
—L.
(
T REF RA
PICCOLO
10/01/03 01:57 PM
REFERENCE RAN3E: MALE
PATIENT #: 11111 (c4) -(-1
BASIC METABOLIC
DISC LOT #: 3203AA4
OPER /1111 .1-DR #: 000
MRIAL .
GLU 115 73-118 MG/DL
BUN ## 7-22 MG/DL !
CA++ 8.1 8.0-10.3 MG/DL
CRE 0.7 0.6-1,2 MG/DL
NA+ -eV* 128-145 MMOVL
K+ 4.2 3.3-4.7 MMO&L
CL-93* 98-108 MMOVL
tCO2 22 18-33 MMOVL
INST OC: OK CHEM OC: OK
HEM 0 ) LIP 0 . ICT 1+
1CO2 18-33 mmot/I
DOD-033236
:spaqs pagoeue lo JOCIUMN
H H
:NSSJO#lUe Red :eweN ls.qj
r-
o)
3
cp.
7J 0 0
cp a)2
Fiik
CD 0
50D
C)
Do -5D
rn
o
cD CD CD
rn
0
0
eL
Cr
cT
0
-
0
0
0
0
CO *.0
CD
Cn CD C). co '3 o o Q CD (41.
3 co 11
C
n
b -2
MEDCOM - 19663
DOD-033237
Name: Status: Final Patient ID: Source: Blood Collected: Ward/Rm: .3/ Ward of Iso: Attd. Phys:
Acinetobacter baumannii/haemolyticus Status: Final
1 Ac baumann/haem
Druq MIC I nterp s Drug MIC Interps
Amox/K Clay (c) 16/8
Amp/Sulbactam (c) 16/8
Ampicillin 16
Aztreonam 16
Cefazolin 16
Cefepime 16
Cefotaxime (c) 32
Cefotetan 32
Cefoxitin 16
f-ittf
Ceftazidime (a) 16 Ceftriaxone (c) 32 Cefuroxime (b) 16 Cephalothin 16 Chloramphenicol 16 Ciprofloxacin 2 ESBL-a Scrn 4 ESBL-b Scrn 1 Gatifloxacin 4 Gentamicin 8 Imipenem (c) =4 Levofloxacin 4 Meropenem (c) =4 Moxifloxacin 4 Nitrofurantoin 64 Norfloxacin 8 Piperacillin (a) 64 Tetracycline 8 Ticar/K Clay (a) 64 Tobramycin =4 Trimeth/Sulfa 2/38
S = Susceptible N/R = Not Reported Blank = Data not available, or drug not advisable or tested I = Intermediate — = Not Tested ESBL . Extended spectrum beta-lactamase R = Resistance TFG = Thymidine-dependent strain Blac = Beta-lactamase positive MIC = mcg/ml (mg/L)
Ft' = Resistant due to extended spectrum beta-lactamases (ESBL) EBL? = Suspected ESBL. Confirmatory tests needed to differentiate ESBL from other beta-lactamases. IB = Inducible Beta-lactamase. Appears in place of Sensitive with species known to possess inducible beta-lactamases; potentially they may become resistant to all beta-lectern drugs. Monitoring of patients during/after therapy is recommended. Avoid other/combined beta-lactam drugs.
For blood and CSF Isolates, a beta-lactamase test is recommended for Enterococcus species.
(a) Use maximum doses of drug with an aminoglycoside for P. aeruginosa in patients with granulocytopenia or serious infections.
(b) Breakpoints based on parenteral dose. For cefuroxime axetil (PO) use (B=S, 8-16=1, 16=R). Footnote (c) applies to this drug.
(c) For streptococci refer to penicillin interpretations. For amoxicillin/K clavulanate or ampicillin/sulbactam with enterococci, refer to the penicillin interpretation.
(d) For non beta-lactamase producing enterococci, refer to the penicillin interpretation. Footnote (a) also applies to this drug.
Interpretive breakpoints are based on NCCLS M100-S12 Jan 2002. Sparfloxacin (for Gram Negative Isolates) and moxifloxacin are based on FDA approved breakpoints. For S. pneumoniae, cefotexime and ceftriaxone breakpoints are based on isolates from pati , ngilis. For non-meningitis infections, use 2=S, 2=1, 2=R.
Name: Specimen: Status: Final Patient ID: () ii Source: Blood Collected:
Ward/Rm: 2/3 Ward of Iso: Req. Phys:
Printed 10/1/2003 10:15:26 AM Page 1 of 1 Tech: MEDCOM - 19664
DOD-033238
0
cs
()
3 T
(t,
0
Ui
0
qc
k/N
MEDCOM - 19665
DOD-033239
Name: Specimen:. Status:.Final
Patient ID:.
1 4\ Source:.Blood. Collected:
Ward/Rm: U2/3 'C.?. Ward of Iso:. Attd. Phys:
1.Acinetobacter baumannii/haemolyticus Status: Final
1.Ac baumann/haem Drug MIC I nterps Drug MIC Interps Amox/K Clay (c) 16/8 Amp/Sulbactam (c) 16/8 Ampicillin 16 Aztreonam 16 Cefazolin 16 Cefepime 16 Cefotaxime (c) 32 Cefotetan 32 Cefoxitin 16 Ceftazidime (a) 16 Ceftriaxone (c) 32 Cefuroxime (b) 16 Cephalothin 16 Chloramphenicol 16 Ciprofloxacin 2 ESBL-a Scrn 4 ESBL-b Scrn 1 Gatifloxacin 4 Gentamicin 8 Imipenem (c) =4 Levofloxacin 4 Meropenem (c) =4 Moxifloxacin 4 Nitrofurantoin 64 Norfloxacin 8 Piperacillin (a) 64 Tetracycline 8 Ticar/K Clay (a) 64 Tobramycin Trimeth/Sulfa 2/38
S\= Susceptible\ WR = Not Reported\ Blank = Data not available, or drug not advisable or tested I\= Intermediate\ —\= Not Tested\ ESBL = Extended spectrum beta-lactamase R\= Resistance\ TFG = Thymidine-dependent strain\ Mac = Beta-lactamase positive MIC = mcganl(mg/L)
R'\= Resistant due to extended spectrum beta-lactamases (ESBL) ESL? = Suspected ESBL. Confinnatory tests needed to differentiate ESBL from other beta-lactamases. IB\= Inducible Beta-lactamase. Appears In place of Sensitive with species known to possess inducible beta-lactamases; potentially they may become resistant to all beta-lactam drugs. Monitoring of patients during/after therapy is recommended. Avoid other/combined beta-lactam drugs.
For blood and CSF Isolates, a beta-lactamase test Is recommended for Enterococcus species.
(a) Use maximum doses of drug with an aminoglycoside for P. aeruginosa in patients with granulocytopenia or serious infections.
(b) Breakpoints based on parenteral dose. For cefuroxime axed! (PO) use (fS, 8.16=1, 16=R). Footnote (c) applies to this drug.
(c) For streptococci refer to penicillin interpretations. For amoxicillin/K clavulanate or ampicillintsulbectam with enterococci, refer to the penicillin interpretation.
(d) For non bela-lactamase producing enterococci, refer to the penicillin interpretation. Footnote (a) also applies to this drug.
Interpretive breakpoints are based on NCCLS M100-S12 Jan 2002. Sparfloxacin (for Gram Negative isolates) and moxifloxacin are based on FDA approved breakpoints. For S. pneumoniae, cetotaxime and ceftriaxone breakpoints are based on isolates from patien .tis. For non-meningitis Infections, use 2=S, 2=1, 2=R.
Name: Specimen: Status:.Final Patient ID: b( Source:.Blood Collected: Ward/Rm: Ward of Iso: Req. Phys:
Printed 10/1/2003 10:15:26 AM Page 1 of 1 Tech: MEDCOM - 19666
DOD-033240
Ward/Section:. IIMIIIIIIIIF:b ( (.,( \\ —2--
=CU 2-DATE TIME
LAST„FIRST, M I.
2.0 --4, 114n-
,,g1t4,042: ,..,4!..„. , —,14APTIM Ap.
,„,d.4,....,,.1,.,:::::.; ,:e.4sy,lolitmaT,,
TEST RESULT REE RANGE TEST RESULT REE
RANGE
138-146 nunol/dL ALB 3.5-5.5 g/d1
Na
1,)-T
K 3.5-4.9 nunol/L ALP 26-84 u/1
4.3
98-109 nunol/L ALT 10-47 u/1
pH 7.31-7.45 AMY 14-97 till
1 . 9 .D.7
PCO2 35-45 mmHg (art) AST 11-38 u/I
3S".G 41-51 mmHg (ven) 80-105 mmHg (art) TB1L 0.2-1.6 mg/dl
P02
7f(o N/A (ven) 23-27 trunol/L (art) BUN 7-22 mg/d1
TCO2 a)
as_
24-29 mnrol/I (ven)
22-26 nuno1/1., (art) cA++ 8.0-10.3 mg/d1
HCO3
23-28 nunol/L (art) SO2 95-98% CHOL 100-200 mg/d1
q -I
.
'
(-2) (+3)
BEerf CRE 0.6-1.2 mg/di
mmol/L
AnGap 10-20 mmol/L GLU 73-118 mg/di
Ca 1. 03 1.12-1.32 mind& TP 6.4-8.1 g/dI -.,-,4;,-.,
BUN 8-26 mg/dl
'. e' ..4 14$1,„ Itzhv
.1 )
GLU 70-105 mg/d1 TEST RESULT REF
RANGE
73-118 mg/diCreat 0.7-1.5 log/di
GLU
Hct 38-51% PCV BUN 7-22 mg/d1
3 3
0.6-1.2 mg/dl
Hgb i 1 12-17 g/d1 CRE mritsAmir us _.39-380 /1(M)
% CK
ARE...Vilnr....,,,..,, ,,,, ,,,?.., 30,90 ,. (F) TEST RESULT REF. RANGE NA+ 128445 nuno14
3.3-4.7 mmol/1
Tropoin-1
Drug of 98-108 mmol/I
cc
Abuse
tc02 18-33 mmol/1
REMARKS:
CHEMISTRY RESULT FORM (Subject to the Privacy Act of 1974) SSN/PEEUDO SSN:
,
..,.,., ., ''.
'
If...ct: '.....,NrAN'A ' .
TEST .RESULT REF RANGE
73-118 mg/d1
GLU 7-22 mg/d1
BUN 8.0-10.3 mg/dl
CA+ 0.6-1.2 mg/d1
CRE 128-145 mmol/dl
NA+
ICI' 3.3-4.7 mmo1/1
cc 98-108 rnmo1/1
18-33 mmol/1
tCO2
'"D-01...,. `'w
#454 4\kto.,..\4..401.,941E-6.1",
pw *-,v4,.--N ,g
TEST RESULT REF RANGE
ALB 3.3-5.5 g/dI
ALP 26-84 oil
ALT 10-47 u/1
-AST 14-97 u/I
AMY 11-38 u/1 TB1L 0.2-1.6 mg/111 GGT 5-65 u/1
Tp -, 6.4-8.1 g/dI
8
l', ?...-,...,
"'`''' .' .-.•:"."
TEST RESULT REF RANGE
NA+ 128-145 nunolll K+ 33-4.7 mmoLlI CL.-98-108 mmol/1 tCO2 18-33 nonolti
REPORTED BY: DATE: LAB ID NO.:
MEDCOM 19667
-
DOD-033241
Ward/Section: REQUES
CHEMISTRY RESULT FORM
(Subject to the Privacy Act of 1974)
L ST0 FIRST, I.
C9
,00'404hgA gaWAMOMI
TEST RESULT REF RANGE, TEST RESULT REF
RANGE
Na 138-146 mmol/dL ALB 3.5-5.5 g/d1
3.5-4.9 mmol/L 26-84 u/I
ALP PICCOLO . 10/02/03.
11:18 AM
CI 98-109 mmoL/L ALT
10-47 u/I
REFERENCE RANGE:.
MALE
pH 731-7.45 AMY 14-97 u/I PATIENT #: 111111 E,(0J-q
PCO2 35-45 mmHg (art) AST BASIC METABOLIC
11-38 u/1
41-51 mmHg (yen)
DISC LOT #:.
3203AAI
PO2 80-105 mmHg (art) TBIL 0.2-1.6 mg/dl
N/A (ven) OPER # t, DR #: 000 23-27 mmol/L (art)
TCO2 BUN 7-22 mg/di SERIAL #: \u
24-29 mmol/L (ven)
22-26 mmol/L (art) ++
HCO3 CA 8.0-10.3 mg/dll
23-28 nurrol/L (art) GLU 131* 73-118 MG/DL
SO2. 95-98% CHOL 100-200 mg/dl BUN m 7-22 MG/DL
BEccf (-2) - (+3) CA++ 8.5 8.0-10.3 MG/D.
CRE 0.6-1.2 mg/di 1mmol/L
CRE 0.4* 0.6-1.2 MG/DL
AnGap. 10-20 mmol/L GLU 73-118 mg/dl I
+1144---4424 128-145 MMOUL
Ca 1.12-1.32 mmol/L TI' 6.4-8.1 g/dI
K+ 5.0* 3.3-4.7 MMOVL
6
BUN 8-26 mg/dl 415 Anh\CL-98 98-108
MMOVL
GLU 70-105 mg/dl TEST RESULT REE tCO2 22 18-33 MR.
i
RANGE
INST OC: OK.
CHEM OC: OK
Creat 0.7-1.5 ing/t11 73-118 mgh11 17
GLU HEM 1+, LIP 0 , ICT 0
Hct 38-51% PCV.BUN 7-22 mg/dl .
. -
12-17 g/dI 0.6-1.2 mg/d1
Hgb CRE
CK 39-380 /1(M)
A 30-190 /1 (17) .-
TEST RESULT REF RANGE NA+ 128-145 mmol/1
3.3-4.7 inmoVI -
Tropoin-1 K+
Drug of Cr 98-108 nuno1/1 Abuse
tCO2 18-33 mmo
tCO2 18-33 Milton
REMARKS:
REPORTED BY: DATE: LAB ID NO.:
MEDCOM -19668
DOD-033242
Ward/Section: REQUEST!. CHEMISTRY RESULT FORM
• b l cit.-2
(Subject to the Privacy Act of 1974)
11 U.-1— q-..
.....
DATE TIME
LAST, Fl RST,M1..191o),-(-1
....11.Alb.
11L.
it -s:,-11i$ :t-4'\,t(P , ., „ .c.411,,,l,..t.
,;-..f. it, 4,45; -.....:,,4 ,,,: . ..44,\--v4v, .., k,... Aq,.\ AVVVtl.-z.:4--,, 2,'.4
tlylfg-4M• IPAIMIX.MtVo ..1';%'°-`•:-. `. A$v"es‘,...gb0We'tiPs•-.4W
EST RESULT REE.GE TEST RESULT REE TEST RESULT REE RANGE RANGE
138-146 nunol/dL ALB 3.5-5.5 g/41 73-118 mg/d1
Na GLU
K 3.54.9 nunol/L ALP 26-84 u/1 BUN 7-22 mg/ll
8.0-10.3 mg/di
CI 98-109 mnrol/L ALT 10-47u/1 CA ++
pH -7, 47% 0 7.31-7.45 AMY 14-97 u/I CRE 0.6-1.2 mg/dI
PCO2 3 ii) • v 35-45 mmHg (art) AST 11-38 u/I NA+ 128-145 rnmol/d1 41-51 mmHg (yen)
P02 Ilg (art) TBIL 0.2-1.6 mg/dI K+ 3.3-4.7 mmo1/1
sg-?-81:/-1°n)
(!emin7.3-27 nunol/L (art) BUN 7-22 mWdl 98-108 mmon
TCO2 CL
)i3 24-29 mmol/L (ven)2.--)._ 22-26 nunoUL (art) rng/d1 18-33 nunoV1
HCO3 CA tCO2
23-28 mmol/L (art)
SO2 9 i_-95-98% CHOL .ORIUP:
S'10471344OVINW .44i,
10°-2°° nigicil ,r. -e2:**.
REE RANGE
BEecf 4-3) CRE 0.6-1.2 mg/d1 TEST RESULT
(2) 1)(
ol/
AnGap y 10-20 mmol/L GLU 73-118 mg/d1 ALB 3.3-5.5 g/r11
11 rnmL
Ca 1.12-1.32 mmol/L TI' 6.4-8.1 g/d1 ALP 26-84 u/I
8-.:,.iija. .,„,.itolo ALT
'.'1".,s.'-', 04-:4b. ¦-?....,i'l ,..f .... ,Ix?7:-VAIA•z:::
GLU 70-105 mg/d1 TEST RESULT REE AST 14-97 u/1
RANGE
BUN 8-26 mg Vii:Riek.1 ii (.1irk ,, , ,„„ , 10-47 u/1
0.7-1.5 mg/d1 73-118 mg/111 AMY 11-38 u/1
Creat GLU
Hct 38-51% PCV BUN 7-22 mg/dI TBIL 0.2-1.6 mghll
0.6-1.2 mg/III
12-17 g/d1 CRE GGT 5-65 u/I CK 39480 4 (m) TP 6.4-8.1 g/d1
TEST RESULT REF. RANGE NA+ 128-145 nutto1/1
.
-
3.3-4.7 mmoUl TEST RESULT REF RANGE
K+
Tropoin-1 . . Drug of CL-98-108 trunol/1 NA+ 128-145 mmo1/1 Abuse
tCO2 18-33 mmol/1 K+ 3.3-4.7 mmolil
CL 98-108 nuno1/1
.
' tCO2 18-33 mmoIJI
REMARKS:
REPORTED BY: DATE: LAB ID NO.:
a z.. /4-. _,
1 6/V /60'.F. z
MEDCOM -19669
DOD-033243
WaL : REQUESTING PHYSICAN: CHEMISTRY RESULT FORM
(Subject to the Privacy Act of 1974)
DATE TIME SSN/PEEUDO SSN:LAST, FIRST,MI.
. --$F4-..gA.---g- ..., .;,.,,.
V.., .1, ", ekg,, * ::va,„,01 '.:,,,% . : .0 0. MI ,.,, ' •/..' '.,,,4 S. ° 4..s,4..)1.t1.V.,..171/,„
' ' ,,,1; tgi
RESULT .REE RANGE
TEST RESULT REE. RANGE TEST RESULT REE TEST
RANGE
Na 3.5-5.5 g/dI 73-118 mg/dl
138-146 mmoi/dL ALB GLU
26-84 u/I 7-22 mg/dl3.5-4.9 nunol/L
K ALP BUN
8.0-10.3 mg/dl
98-109 nunoUL ALT 10-47 u/I CA++ 0.6-1.2 mg/dl
pH 7.31-7.45 AMY 14-97 u/I CRE
128-145 mmol/dl
co35-45 mmHg (art) AST 11-38 WI NA
P2
41-51 mmHg (ven) 80-105 nunlig (art) T. 3.3-4.7 mmul/I
PO2 IC+
N/A (ven)
23-27 mmol/L (art) I. I-98-108 mmoUl
TCO2
24-29 mmol/L (ven) .; PICCOLO --. 22-26 mmoUL (art) 04:44 AM CO2 18-33 nno1/1
HCO3 10/03/03.
(.
23-28 mmoUL (art)
MALE it...
ERENCE Rill 6(02
REF.
c.
SO2 95-98% ',..„„Tk.-.7...,,,„....,,.;110494r:
rl.,
-k
PATIENT #:
RESULT REE RANGE
(-2) - (+3) ST
BEecf C.
nunol/ L MEILYTE 8
'p 3.3-5.5 g/dI
AnGap 10-20 enrnol/L.G.DISC LOT #:3141AA4./1/DR # . 0 0.26-84 u/I
' r
Ca 1.12-1.32 mmoUL T1.OPER #.BUN 8-26 mg/dl gi:F.;-..:.SERIAL.
#:.\2( 7 10 47 un
4,„ki.
...
................
."...
'.7,
: 14-97 u/1
70-105 mg/dl MG/DL.
GLU 73-1 18.
GLU 109 •
—.
MG/DL.
BUN 10 7-22.
,
MG/DL.11-38 u/I
CI,
Creat 0.7-1.5 mg/dl GI;.0.6-1.2.
0.9.
CRE
U/L 0.2-1.6 mg/dlHct 38-51% PCV CK.
BUI 3821'4,39-38°.
MHOI/LL
444-1.7)128-145
NA+.5-65 WI
Hgb 1217 g/d1 CRI.MMULL
3.3-4.7.
6.481 g/dI
d...'....,..' -.1 4 'S*''' 'I CK MMOUL
98-108.
rys..a,.
.„4,-w CL-99.
tf.. — , . , " . -...,.
20.
°111-
18-33.• cillo
TEST RESULT REF. RANGE NA+.tCO2
..:, 0:04
\ —\
CHEM OC: OK.RESULT REF. RANGE
INST OC: OK.,
-
Tropoin1 K+.
ICT 0
LIP 0 ,.
HEM 0 ,
Drug of CL 128-145 mmol/I
Abuse .
tCO2 3.3-4.7 mmol/1
98-108 nuno1/1
18-33 mmo1/1
REMARKS:
REPORTED BY: DATI
MEDCOM 19670
-
DOD-033244
. Ward/Section:. REQU ESTI (L2 7.CHEMISTRY RESULT FORM
.
..... (4 — LAST, FIRST,M1.
• /.-Lk
a
TEST
Na
/K/-----
CI
pH
PCO2
PO2
TCO2
HCO3
SO2
BEecf
A • Gap Ca
BUN
GLU
Creat
Hct
Hgb
, ,,,, 40,.,..._ '''''.4. AMBI;"-Wm,
RESULT REE RANGE
138-146 mmol/dL
.
----,-------------
-)..cia I
fs\,, i
---) ,2,
-?... (g.
--4 (4,
2
3-.5-4.9a'nolk
98-109 mmoUL
7.31-7.45 347:1I mmHg (art)
80-105 mmHg (art)
N/A (ven) 23-27 mmoUL (art) 24-29 nunol/L (ven)
22-26 mmoUL (art) 23-28 nunol/L (art) 95-98% (-2)- (+3)mmoUL 10-20 mmoUL 1.12-1.32 mmol/L 8-26 mg/dl
70-105.,•.., .
0.7-1.5 rug/di 38-51% PCV 12-17 g/dl
41494.1rf. ,A4 kika''t.4.-.,. Xff.VA.4
TEST RESULT REE RANGE
Tropoin-1
Drug of Abuse
REMARKS:
REPORTED BY:
E TIME
-ebr -0 p 70
'7,,?.,. 1 01.Itgaiir
AMMO '''\j'AP.Mg, ''
TEST RESULT
ALB
AL •
ALT
1AMY
AST
TBIL
BUN
CAP+
CHOL
GLU
T' .
:-/.q, t, .,. ., "V'..
TEST RESULT
GLU
BUN
CRE
CK
NA+
le
Cl:
ICO2
DATE:
REE
RANGE
3.5-5.5 g/d1
26-84 u/I
1047 u/1 14-97 u/1 11-38 u/1
0.2-1.6 mg/dl 7-22 mg/dl 8.0-10.3 mg/d1
100-200 mg/dl 0.6-1.2 mg/dl 73-118 mg/dl 6.4-8.1 g/dl.' -,-.6.
,.'•.'''
REE
RANGE
73-118 mg/dl
7-22 mg/di 0.6-1.2 mg/dl 39-380 /I (M)
30-190 /I (F)
(Subject to the Privacy Act of 1974)
,,,:;,,i:.,
'1-1,-.;
TEST
GLU BUN
CA++
0.6-1.2 mg/dl
CRE
128-145 mmol/dl
NA+
3.3-4.7 nuno1/1 Ci: 98-108 nuno1/1 18-33 namol/1
tCO2
v.4601101.. P061:!'
TEST
ALB ALP ALT
AST
AMY TBIL GGT Tp
.; '..a.,,s,-.
(CP
cc1I C) ,,,,,,,;(.-
7....v.;
„,.:.:\'...A.-.&C-,`.'k'ts
RESULT REE RANGE
73-118 mg/dl 7-22 mg/dl 8.0-10.3 mg/dl
.. .Acf.s-lsw....-r%,...N4,:e.e-.,:0.,...t
RESULT REE RANGE
3.3-5.5 g/dl 26-84 u/I 10-47 till
, 14-97 u/I
11-38 WI 0.2-1.6 mg/dl 5-65 u/I
6.4-8.1 g/dl
128-145 mmol/I ',5V -.&..31,11.'.Of ;A.,,; .'I "-; -
.4^,, ,,.'1.. 3.3-4.7 nunon TEST RESULT REE RANGE 98-108 mmoUI NA+ 128-145 mmol/1 18-33 mmot/1 K+ 3.3-4.7 mmol/1 C1,--98-108 mmolll tCO2 18-33 mmol/1
LAB ID NO.:
.
z
/0o
MEDCOM - 19671
DOD-033245
Ward/Section: REQUEST
.-7-7A/1-i 7 \l' 4
LAST,.FiiRs ,m
T
.,,,,,,,,,
0,......-nf,..z,.\M,,,\t\.,4!t Ott"
-z-\v..., ,ivpw.
v ,, , 4,,.',wwlv., --,,*\k.;:-.1.',:',:16-0!-f?..e' ,
„ ,,
,,,, .
TEST .RESULT .REF RANGE
138-146 nunol/dL
Na.
3.54.9 nuno1/1..
K.
98-109 mmoUL
Ct`-------.1.
PH PCO2 P02
T CO2
HCO3 SO2 BEecf
AnGap
BUN
GLU
Creat
Hct
.7. tActsis.7.31-7.45 4I-.5. inual/ (art)
I I . et.3n
80-105.Hg (art)
SI.N/A (ve 7_, 3_.Fil; 11&aertn))
m0
22-26.on (art) 2 G.23-28.olfl. (art)9 5.95-98 /9
J.- (+3)mmoUL 10-20 mmol/L 1.12-1.32 nunoUL 8-26 mg/d1
70-105 mg/dl
0.7-1.5 mg/dl
.38-51% PCV
Hgb. 12-17 Oil
.:
? :fz.lkit,". ,. , 11;0
':
TEST RESULT REF. RANGE
Tropoin-1
Drug of
Abuse
REMARKS:
REPORTED CHEMISTRY RESULT FORM
(Subject to the Privacy Act of 1974) ATE TIME SSN/'.N:
oc.71 c, iyat, ' '' 0:POr— ,,,.. ,.\v eit4
00 , „ : —.,0.04
TEST RESULT REF RANGE
3.5-5.5 g/d1
ALB
26-84 u/I
ALP ALT 10-47 u/1 AMY 14-97 un AST 11-38 on
TBIL 0.2-1.6 mg/d1 BUN 7-22 mg/di 8.0-10.3 mg/dl
CA++ CHOL 100-200 mg/di CRE 0.6-1.2 mg/di
GLU 73-118 mg/di TP 6.4-8.1 01 gaW ' ,it
”
441L 0.,,',,,44; 1
'
,
TEST RESULT REF RANGE
73-118 mg/dI
GLU
7-22 mg/di
BUN
0.6-1.2 mg/d1
CRE
39-380 /I (NI)
CK
30-190 /I (F) 128-145 mmul/1
NA+
3.3-4.7 nunol4
K+
98-108 mmoin
CI:
tCO2 18-33 mmol/1
\
DATE: LAB ID NO.:
TEST .RESULT REE RANGE
73-118 mg/dl
GLU 7-22 mg/d1
BUN 8.0-10.3 mg/di
CA++ 0.6-1.2 mg/dl
CRE , 128-145 nunol/d1
NA rK+ 3.3-4.7 mmol/1
98-108 mmoUl 18-33 mmol/1
CI:
tan
''' ....":4, '., 7041.,i, ,,. ,:,..,*.. 4#4011
..f.
TEST RESULT REF RANGE
I
ALB 3.3-5.5 01
ALP 26-84 u/I
ALT 10-47 u/I
AST 14-97 u/I
AMY 11-38 u/1
TBIL 0.2-1.6 mg/d1
GGT 5-65 u/1.-TP 6.4-8.1 g/dI re.„ ife.)",--
TEST RESULT REF RANGE
NA+ 128.145 moll!
K+ 3.3-4.7 mmolll
Cr 98-108mmoUl
tCO2 18-33 mmol/1
[Q0 -..35c1.3
MEDCOM -19672
DOD-033246
k Ward/Section:.. '\4 REQUEST].-CHEMISTRY RESULT FORM -
(Subject to the Privacy Act of 1974)
_... TIME SS /P
LAST, FIRST,MI. \r.) ( t) 1-
-.
.., 4:iiiii1040 AO .-A •,,,.4.6,4taitgii gaig, itemo.:, a-.m., : .:,„\Piccolo) ,,1:u. :bolicPanel
..14 ;-*AtiafgtX0 Oriatt#042gEW, -"-. '''''' aitk*AVV05,...**,,-:,-16, CROIA1
WficfNik '.4540.,
RESULT REF RANGE
TEST IA # T REE RANGE TEST RESULT REE TEST
RANGE
3.5-5.5 g/d1 73-118 ing/d1
138-146 mmoi/dL ALB GLU
Na
7-22 mg/d1
K 3.5-4.9 mmol/L ALP 26-84 u/I BUN 8.0-10.3 mg/d1
98-109 nunol/L ALT 10-47 u/I CA++
CI
0.6-1.2 mg/t11
pH 7 . 1-1 2 3 7.31-7.45 AMY 14-97 u/I CRE 34711 nunll: ((arnAST 128-145 mmol/di
PCO2 Li i , ,13 vet)) 11-38 u/1 Ne
P02 80-105 mmHg (art) TBIL 0.2-1.6 mg/d1 K+ 3.3-4.7 mmo1/1
-4-9 N/A (ven) 23-27 mmol/L (art) BUN 7-22 mg/dl Cr 98-108 nuno1/1
TCO2
2-% 24-29 mmon (ven) 18-33 mmolll
22-26 nunoUL (art) 8.0-10.3 ing/d1
HCO3 CA tCO2 SO2 95-98% CHOL 100-200 ing/d1 PiIr..1"ahiPir.itiOrt.4 ' '4,0
REF RANGE
BEecf ("2) - (+3) CRE 0.6-1.2 mg/d1 TEST RESULT
'4_ mmol/L 73-118 mg/d1 ALB 3.3-5.5 g/dl
AnGap . 10-20 tnmoVL GLU
26-84 u/I
Ca 1.12-1.32 mmol/L Ti' 6.4-8.1 g/d1 ALP
BUN 8-26 mg/til ''4.fP.(P iccolo1 , t• Otill. ALT 1041 till
,.tve.o.e
GLU 70-105 ing/d1 TEST RESULT REF AST 14-97 u/I
RANGE
73-118 Ing/dI AMY 11-38 u/1
Creat 0.7-1.5 mg/dl
GLU 0.2-1.6 mg/dI
Hct 38-51% PCV BUN 7-22 mg/ill TBIL
0.6-1.2 ing/dI GGT 5-65 u/I
Hgb 12-17 g/dl CRE
..-.......o... E.,‘.: 39-380 /I (M) 6.4-8.1 g/dl
kottati:443fi , I? '110,444: CK 30-140 /I (F) TP
,.9, 4:4,
:...W:dfg4t4V td 1440-`,..\
TEST RESULT REF. RANGE NA+ 128-145 nutto1/1 ' 004,„ 1,7,0M
3.3-4.7 mmol/1 TEST RESULT REF RANGE
K
Tropoin-1
Drug of CC 98-108 mmol/1 NA+ 128-145 mmo1/1 Abuse
• 1CO2 18-33 nuno1/1 K+ 3.3-4.7 romoUl
_
ar . 98-108 mmal
tCO2 18-33 mmoVI
A A.n /
REMARKS:
967,3
fO c"--r-id.-74-_,.
REPORTED BY: DATE: LAB ID NO.:
MEDCOM - 19673
DOD-033247